Search Results 851-860 of 16736 for Imiglucerase

  1. Some medicines or supplements can cause of hyperkalemia, including: Angiotensin-converting enzyme (ACE) inhibitors · Angiotensin II receptor blockers · Beta ...

  2. Correlative Biomarker Study in Patients With Myeloproliferative Disorders - Mayo Clinic

    Researchers will use abnormal blood and/or bone marrow cells, or materials derived from these abnormal cells, like DNA, RNA, protein or plasma, in laboratory ...

  3. Mesenteric ischemia - Doctors and departments - Mayo Clinic

    This condition can come on suddenly or develop over time. Find out more about symptoms and treatment for this condition that restricts blood flow to the ...

  4. Mesenteric ischemia - Doctors and departments - Mayo Clinic

    This condition can come on suddenly or develop over time. Find out more about symptoms and treatment for this condition that restricts blood flow to the ...

  5. A Study to Compare the Effectiveness of an Invasive Treatment Approach versus Conservative Medication Alone Strategy for Patients with Stable Ischemic Heart Disease - Mayo Clinic

    About this study. The purpose of this study is to determine if an initial invasive strategy of cardiac catheterization and optimal revascularization with ...

  6. Neurosurgery - Clinical trials

    Learn how neurosurgeons help people with complex conditions by using advanced techniques, such as awake brain surgery and minimally invasive spine surgery.

  7. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  8. Erythromycin and sulfisoxazole (oral route) - Side effects & dosage - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  9. Mesenteric ischemia - Doctors and departments - Mayo Clinic

    This condition can come on suddenly or develop over time. Find out more about symptoms and treatment for this condition that restricts blood flow to the ...

  10. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

    The purpose of this study is to evaluate the safety of alisertib and its effect, bad and/or good, on acute megakaryoblastic leukemia (AMKL) or myelofibrosis (MF) ...